IP Library Assignment 037262/0569
Patent Assignment
Reel/Frame 037262/0569

Assignment of Assignor's Interest

Recorded: 2015-12-10 Pages: 6
Assignors
WESTMAN, JACOB
Executed: 2012-02-03
HALLETT, ALLAN
Executed: 2012-01-31
VAGBERG, JAN
Executed: 2012-02-08
Assignee
BETAGENON AB
BOX 7966, UMEA, S907 19, SWEDEN
Covered Property (1)
1,2,4-Thiazolidin-3-One Derivatives and Their Use in the Treatment of Cancer
Patent: 9,675,596 →
Application: 14/883,190 →
Publication: US 2016/0128993
Related Assignments (7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 22, 2016
From: BETAGENON AB
To: BALTIC BIO AB
Reel/Frame 037560/0337 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 37560 Frame 337. Assignor(S) Hereby Confirms the Assignment. Jun 27, 2024
From: AB, BETAGENON
To: BALTICGRUPPEN BIO AB
Reel/Frame 068654/0045 →
Confirmatory Assignment Nov 8, 2024
From: BETAGENON AB
To: BALTICGRUPPEN BIO AB
Reel/Frame 069333/0078 →
Change of Name Dec 11, 2024
From: BALTICGRUPPEN BIO AB
To: BETAGENON AB
Reel/Frame 069887/0919 →
Change of Address Dec 11, 2024
From: BETAGENON AB
To: BETAGENON AB
Reel/Frame 069590/0703 →
Change of Address Dec 11, 2024
From: BALTICGRUPPEN BIO AB
To: BALTICGRUPPEN BIO AB
Reel/Frame 069715/0586 →
Change of Address Feb 20, 2025
From: BALTICGRUPPEN BIO AB
To: BALTICGRUPPEN BIO AB
Reel/Frame 070274/0675 →